INS and Insulin resistance: Conventional GC therapy has already been reported negatively to affect insulin requirement in patients with APS and type 1 diabetes, compared to patients with only type 1 diabetes, mainly due to non-physiological daily GC availability, notably in the evening, inducing an increase in insulin resistance (33, 34).